Lobular Breast Cancer: Same Survival and Local Control Compared with Ductal Cancer, but Should Both Be Treated the Same Way? Analysis of an Institutional Database over a 10-Year Period

[1]  G. Ott,et al.  Clinical impacts of histological subtyping primary breast cancer. , 2010, Anticancer research.

[2]  R. Mann.  The effectiveness of MR imaging in the assessment of invasive lobular carcinoma of the breast. , 2010, Magnetic resonance imaging clinics of North America.

[3]  Nabil Wasif,et al.  Invasive Lobular vs. Ductal Breast Cancer: A Stage-Matched Comparison of Outcomes , 2010, Annals of Surgical Oncology.

[4]  Yao-Tseng Chen,et al.  Clonal relationship between closely approximated low-grade ductal and lobular lesions in the breast: a molecular study of 10 cases. , 2009, American journal of clinical pathology.

[5]  A. Luini,et al.  Lack of prognostic significance of “classic” lobular breast carcinoma: a matched, single institution series , 2009, Breast Cancer Research and Treatment.

[6]  W. Farrar,et al.  Contralateral Prophylactic Mastectomy for Unilateral Breast Cancer: An Increasing Trend at a Single Institution , 2009, Annals of Surgical Oncology.

[7]  C. Claussen,et al.  Risk-benefit analysis of preoperative breast MRI in patients with primary breast cancer. , 2009, Clinical radiology.

[8]  R. Brem,et al.  Invasive lobular carcinoma: detection with mammography, sonography, MRI, and breast-specific gamma imaging. , 2009, AJR. American journal of roentgenology.

[9]  A. Luini,et al.  Conservative surgery in patients with multifocal/multicentric breast cancer , 2009, Breast Cancer Research and Treatment.

[10]  L. Hao,et al.  Interobserver variability and aberrant E-cadherin immunostaining of lobular neoplasia and infiltrating lobular carcinoma , 2008, Modern Pathology.

[11]  A. Luini,et al.  Clinicopathologic characteristics of invasive lobular carcinoma of the breast , 2008, Cancer.

[12]  L. Fortunato,et al.  Sentinel lymph node biopsy in breast cancer. , 2008, Surgical oncology clinics of North America.

[13]  M. Kerin,et al.  Prospective matched‐pair comparison of outcome after treatment for lobular and ductal breast carcinoma , 2008, The British journal of surgery.

[14]  U. W. Jayasinghe,et al.  Is Survival from Infiltrating Lobular Carcinoma of the Breast Different from That of Infiltrating Ductal Carcinoma? , 2007, The breast journal.

[15]  H. Kuerer,et al.  Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma. , 2006, American journal of surgery.

[16]  Hanina Hibshoosh,et al.  Interobserver agreement and reproducibility in classification of invasive breast carcinoma: an NCI breast cancer family registry study , 2006, Modern Pathology.

[17]  S. Singletary,et al.  Treatment Trends in Early-Stage Invasive Lobular Carcinoma: A Report From the National Cancer Data Base , 2005, Annals of surgery.

[18]  L. Solin,et al.  Similar long‐term results of breast‐conservation treatment for Stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast , 2005, Cancer.

[19]  H. Carmalt,et al.  Infiltrating lobular carcinoma--a comparison of diagnosis, management and outcome with infiltrating duct carcinoma. , 2004, Breast.

[20]  J. Coebergh,et al.  Prognostic value of morphology and hormone receptor status in breast cancer – a population-based study , 2004, British Journal of Cancer.

[21]  R. Elledge,et al.  Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome , 2004, Breast Cancer Research.

[22]  J. Daling,et al.  Risk of mortality by histologic type of breast cancer among women aged 50 to 79 years. , 2003, Archives of internal medicine.

[23]  C. Cox,et al.  Effect of 0.5 Tesla magnetic resonance imaging on the surgical management of breast cancer patients. , 2003, American journal of surgery.

[24]  E. Yıldırım,et al.  Is invasive lobular carcinoma different from invasive ductal carcinoma? , 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[25]  T. Lioe,et al.  Surgical treatment for invasive lobular carcinoma of the breast. , 2003, Breast.

[26]  Umberto Veronesi,et al.  Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. , 2002, The New England journal of medicine.

[27]  A. Cleton-Jansen.  E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer? , 2001, Breast Cancer Research.

[28]  P. Porter,et al.  Changing incidence rate of invasive lobular breast carcinoma among older women , 2000, Cancer.

[29]  L. Tabár,et al.  10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  K. Bland,et al.  A comparative analysis of lobular and ductal carcinoma of the breast: presentation, treatment, and outcomes. , 1998, Journal of the American College of Surgeons.

[31]  M. J. van de Vijver,et al.  Simultaneous loss of E‐cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ , 1997, The Journal of pathology.

[32]  K. Bland,et al.  Optimal surgical treatment of invasive lobular carcinoma of the breast , 1997, Annals of Surgical Oncology.

[33]  T. Yeatman,et al.  Bilaterality and recurrence rates for lobular breast cancer: Considerations for treatment , 1997, Annals of Surgical Oncology.

[34]  F. Rilke,et al.  Conservative surgery for infiltrating lobular breast carcinoma , 1997, The British journal of surgery.

[35]  I. Gage,et al.  Long-term outcome following breast-conserving surgery and radiation therapy. , 1995, International journal of radiation oncology, biology, physics.

[36]  A. Rosenberg,et al.  Ten‐year results in 1070 patients with stages I and II breast cancer treated by conservative surgery and radiation therapy , 1995, Cancer.

[37]  F. Vicini,et al.  Conservative surgery and radiation therapy for infiltrating lobular carcinoma of the breast: The role of preoperative mammograms in guiding treatment , 1994, Cancer.

[38]  M. Silverstein,et al.  Infiltrating lobular carcinoma: Is it different from infiltrating duct carcinoma? , 1994, Cancer.

[39]  A. Giuliano,et al.  Conservation therapy for invasive lobular carcinoma of the breast , 1992, Cancer.

[40]  I. Ellis,et al.  An evaluation of differences in prognosis, recurrence patterns and receptor status between invasive lobular and other invasive carcinomas of the breast. , 1991, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[41]  D. Fischer,et al.  Conservative surgery with radiation therapy in clinical stage I and II breast cancer. Results of a 20-year experience. , 1989, Archives of surgery.

[42]  I. Ellis,et al.  Invasive lobular carcinomas of the breast--the prognosis of histopathological subtypes. , 1989, British Journal of Cancer.

[43]  S. Schnitt,et al.  Influence of infiltrating lobular histology on local tumor control in breast cancer patients treated with conservative surgery and radiotherapy , 1989, Cancer.

[44]  W. Thompson,et al.  Risk of contralateral breast cancer associations with histologic, clinical, and therapeutic factors , 1988, Cancer.

[45]  T. Mate,et al.  A clinical and histopathologic analysis of the results of conservation surgery and radiation therapy in stage I and II breast carcinoma , 1986, Cancer.

[46]  M. Lesser,et al.  Multicentricity and bilaterality in invasive breast carcinoma. , 1982, Surgery.

[47]  B. Fisher,et al.  The pathology of invasive breast cancer A Syllabus Derived from Findings of the National Surgical Adjuvant Breast Project (Protocol No. 4) , 1975, Cancer.

[48]  A. Huvos,et al.  Infiltrating lobular carcinoma of the breast , 1973, Cancer.

[49]  T. King.  Patient and Surgeon Characteristics Associated with Increased Use of Contralateral Prophylactic Mastectomy in Patients with Breast Cancer , 2011 .

[50]  Elizabeth B. Habermann,et al.  Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients , 2011 .

[51]  E. Mallon,et al.  Relapse of invasive lobular carcinoma. , 2008, Breast disease.

[52]  S. Singletary,et al.  Role of conservation therapy for invasive lobular carcinoma of the breast , 2006, Annals of Surgical Oncology.

[53]  S. Jaffer,et al.  Chapter 9 – Pathology of Invasive Breast Cancer , 2005 .

[54]  S. Schnitt,et al.  The influence of infiltrating lobular carcinoma on the outcome of patients treated with breast-conserving surgery and radiation therapy , 2004, Breast Cancer Research and Treatment.

[55]  D. Schultz,et al.  Fifteen-year results of breast-conserving surgery and definitive irradiation for Stage I and II breast carcinoma: the University of Pennsylvania experience. , 2004, International journal of radiation oncology, biology, physics.

[56]  A. Vincent-Salomon,et al.  Infiltrating lobular carcinoma of the breast: Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns , 1996, Cancer.

[57]  M. Silverstein,et al.  Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma? , 1994, Cancer.

[58]  D. Schultz,et al.  Outcome of conservative therapy for invasive breast cancer by histologic subtype. , 1992, International journal of radiation oncology, biology, physics.

[59]  R. Millis.  Infiltrating Lobular Carcinoma , 1984 .

[60]  F. W. Foote,et al.  A histologic classification of carcinoma of the breast. , 1946, Surgery.